Trial Profile
Efficacy and safety of adalimumab in Japanese patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2016 New trial record
- 15 Jun 2016 Results published in The Journal of Rheumatology